CLINICAL SIGNIFICANCE OF BCL–2 GENE EXPRESSION FOR THE PROGNOSIS AND MONITORING OF ACUTE GRAFT–VERSUS–HOST–DISEASE (AGVHD) IN ALLO–HSCT
Abstract. Our general purpose was to investigate bcl–2 gene expression in patients treated by allogeneic unrelated haematopoietic stem cells transplantation (aUHSCT) for the evaluation of aGvHD. Total RNA from the leukocytes of 19 oncohaematological patients was collected before starting the conditi...
Guardado en:
Autor principal: | M. I. Zaraiski |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8236ac54e2c74d2a8aaf769eb606f73b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
IMMUNOBIOLOGY OF ACUTE GRAFT-VERSUS-HOST DISEASE
por: G. A. Efimov, et al.
Publicado: (2016) -
Impact of graft-versus-host disease prophylaxis on immune reconstitution in patients after allogeneic hematopoietic stem cell transplantation
por: E. D. Mikhaltsova, et al.
Publicado: (2021) -
Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients
por: Wei C, et al.
Publicado: (2021) -
LYMPHOPENIA AS A FACTOR INVOLVED IN THE AUTOIMMUNITY DEVELOPMENT IN MURINE GRAFT VS. HOST DISEASE
por: E. V. Goiman, et al.
Publicado: (2012) -
Sirolimus versus imatinib in patients with steroid-refractory chronic graft-versus-host disease: a retrospective analysis of a single-center
por: HE Yundi, et al.
Publicado: (2021)